SKI Market

Indian Indices

Sensex

83,277.15 650.39
( 0.79%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

56,974.47 32.50
(0.06%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cholamandalam Investment & Finance Company Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

511243

INE121A01024

332.5875808

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CHOLAFIN

30.04

145545.21

EPS(TTM)

Face Value()

Div & Yield %

56.89

0.12

Back

Sun Pharma Advanced Research Company reports consolidated net loss of Rs 80.42 crore in the December 2025 quarter

Feb 09,2026

Net Loss of Sun Pharma Advanced Research Company reported to Rs 80.42 crore in the quarter ended December 2025 as against net loss of Rs 79.51 crore during the previous quarter ended December 2024. Sales declined 43.33% to Rs 8.45 crore in the quarter ended December 2025 as against Rs 14.91 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	8.45	14.91	-43
OPM %	-670.30	-494.23	-
PBDT	-65.42	-76.30	14
PBT	-67.99	-79.44	14
NP	-80.42	-79.51	-1

83,277.15 650.39 ( 0.79%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

56,974.47 32.50 (0.06%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)